Most importantly, CK2 inhibition obtained with chemicals caused a consistent drop of the levels of phospho NF-κB and phospho STAT3 in MM and MCL cells, with a consequent down-regulation of a set of target genes. The gene discussed is NFKB1; the disease is Miyoshi myopathy.